- Home
- IEX vs PODD Comparison
IEX vs PODD Comparison
Compare IEX & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IEX | PODD |
|---|---|---|
| Founded | 1987 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.8B | 17.0B |
| IPO Year | 1994 | 2007 |
Fundamental Metrics
Financial Performance| Metric | IEX | PODD |
|---|---|---|
| Price | $199.11 | $202.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 20 |
| Target Price | $229.63 | ★ $349.80 |
| AVG Volume (30 Days) | 727.5K | ★ 785.7K |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.39% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 6.41 | 3.48 |
| Revenue | ★ $3,457,500,000.00 | $2,708,100,000.00 |
| Revenue This Year | $4.09 | $24.59 |
| Revenue Next Year | $4.36 | $19.18 |
| P/E Ratio | ★ $31.91 | $57.88 |
| Revenue Growth | 5.77 | ★ 30.73 |
| 52 Week Low | $157.25 | $194.61 |
| 52 Week High | $217.16 | $354.88 |
Technical Indicators
Market Signals| Indicator | IEX | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 54.78 | 32.57 |
| Support Level | $175.80 | N/A |
| Resistance Level | $212.00 | $299.75 |
| Average True Range (ATR) | 4.55 | 6.16 |
| MACD | 1.86 | 0.44 |
| Stochastic Oscillator | 69.53 | 28.85 |
Price Performance
Historical ComparisonAbout IEX IDEX Corporation
Idex manufactures pumps, flow meters, valves, and fluidic systems for customers in a variety of end markets, including industrial, fire and safety, life science, and water. The firm's business is organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products. Based in Lake Forest, Illinois, Idex has manufacturing operations in over 20 countries and has over 7,000 employees. The company generated $3.5 billion in revenue in 2025.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.